[
  {
    "ts": null,
    "headline": "The Top 5 Analyst Questions From Henry Schein’s Q2 Earnings Call",
    "summary": "Henry Schein’s second quarter drew a negative market reaction, as the company met Wall Street’s revenue expectations but posted non-GAAP earnings below consensus. Management attributed margin pressures primarily to lower pricing in gloves and time-limited promotional initiatives designed to win back lost customers. CEO Stanley Bergman noted that these efforts, while effective in restoring volumes, weighed on profitability. He also cited “lower glove pricing as well as some time-limited targeted",
    "url": "https://finnhub.io/api/news?id=5de069a27628a45c7e16b3b3af12ce05a17d4b45501b0984f1778e3ac11b974e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755058548,
      "headline": "The Top 5 Analyst Questions From Henry Schein’s Q2 Earnings Call",
      "id": 136328952,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HSIC",
      "source": "Yahoo",
      "summary": "Henry Schein’s second quarter drew a negative market reaction, as the company met Wall Street’s revenue expectations but posted non-GAAP earnings below consensus. Management attributed margin pressures primarily to lower pricing in gloves and time-limited promotional initiatives designed to win back lost customers. CEO Stanley Bergman noted that these efforts, while effective in restoring volumes, weighed on profitability. He also cited “lower glove pricing as well as some time-limited targeted",
      "url": "https://finnhub.io/api/news?id=5de069a27628a45c7e16b3b3af12ce05a17d4b45501b0984f1778e3ac11b974e"
    }
  },
  {
    "ts": null,
    "headline": "HSIC Q2 Deep Dive: Margin Pressures Persist Despite Solid Revenue, New Initiatives Announced",
    "summary": "Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per share was 7.6% below analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=e02350c3c2b4d18ee656375b7d137d3ea967cfb4f9ec52fbaf0b790e1a47a9ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755058023,
      "headline": "HSIC Q2 Deep Dive: Margin Pressures Persist Despite Solid Revenue, New Initiatives Announced",
      "id": 136328953,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HSIC",
      "source": "Yahoo",
      "summary": "Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per share was 7.6% below analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=e02350c3c2b4d18ee656375b7d137d3ea967cfb4f9ec52fbaf0b790e1a47a9ba"
    }
  }
]